Presage Biosciences
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC (NCT06366451) | Presage Biosciences | 2024-05-22 |
| PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS (NCT06413095) | Presage Biosciences | 2022-06-01 |
| Intratumoral Microdosing of Motolimod in HNSCC (NCT04272333) | Presage Biosciences | 2021-10-15 |
| PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC (NCT06062602) | Presage Biosciences | 2021-07-26 |
| Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies (NCT04541108) | Presage Biosciences | 2021-07-26 |
| Intratumoral Microdosing of TAK-981 in Head and Neck Cancer (NCT04065555) | Presage Biosciences | 2020-10-07 |
Track Presage Biosciences automatically
Every clearance here is in the API, with alerts when new ones post.